414 related articles for article (PubMed ID: 30863455)
1. Computational Causal Modeling of the Dynamic Biomarker Cascade in Alzheimer's Disease.
Petrella JR; Hao W; Rao A; Doraiswamy PM
Comput Math Methods Med; 2019; 2019():6216530. PubMed ID: 30863455
[TBL] [Abstract][Full Text] [Related]
2. Personalized Computational Causal Modeling of the Alzheimer Disease Biomarker Cascade.
Petrella JR; Jiang J; Sreeram K; Dalziel S; Doraiswamy PM; Hao W
J Prev Alzheimers Dis; 2024; 11(2):435-444. PubMed ID: 38374750
[TBL] [Abstract][Full Text] [Related]
3. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
[TBL] [Abstract][Full Text] [Related]
5. A data-driven model of biomarker changes in sporadic Alzheimer's disease.
Young AL; Oxtoby NP; Daga P; Cash DM; Fox NC; Ourselin S; Schott JM; Alexander DC;
Brain; 2014 Sep; 137(Pt 9):2564-77. PubMed ID: 25012224
[TBL] [Abstract][Full Text] [Related]
6. A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.
Wang H; Stewart T; Toledo JB; Ginghina C; Tang L; Atik A; Aro P; Shaw LM; Trojanowski JQ; Galasko DR; Edland S; Jensen PH; Shi M; Zhang J;
J Alzheimers Dis; 2018; 61(4):1541-1553. PubMed ID: 29376878
[TBL] [Abstract][Full Text] [Related]
7. Changes in Plasma Amyloid and Tau in a Longitudinal Study of Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Chen TB; Lai YH; Ke TL; Chen JP; Lee YJ; Lin SY; Lin PC; Wang PN; Cheng IH
Dement Geriatr Cogn Disord; 2019; 48(3-4):180-195. PubMed ID: 31991443
[TBL] [Abstract][Full Text] [Related]
8. Disease trajectories in older adults with non-AD pathologic change and comparison with Alzheimer's disease pathophysiology: A longitudinal study.
Li JQ; Song JH; Suckling J; Wang YJ; Zuo CT; Zhang C; Gao J; Song YQ; Xie AM; Tan L; Yu JT;
Neurobiol Aging; 2024 Feb; 134():106-114. PubMed ID: 38056216
[TBL] [Abstract][Full Text] [Related]
9. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
10. Biomarker modeling of Alzheimer's disease.
Jack CR; Holtzman DM
Neuron; 2013 Dec; 80(6):1347-58. PubMed ID: 24360540
[TBL] [Abstract][Full Text] [Related]
11. Suspected non-Alzheimer's pathology - Is it non-Alzheimer's or non-amyloid?
Dani M; Brooks DJ; Edison P
Ageing Res Rev; 2017 Jul; 36():20-31. PubMed ID: 28235659
[TBL] [Abstract][Full Text] [Related]
12. Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity.
Hampel H; Mitchell A; Blennow K; Frank RA; Brettschneider S; Weller L; Möller HJ
J Neural Transm (Vienna); 2004 Mar; 111(3):247-72. PubMed ID: 14991453
[TBL] [Abstract][Full Text] [Related]
13. Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease.
Gangishetti U; Christina Howell J; Perrin RJ; Louneva N; Watts KD; Kollhoff A; Grossman M; Wolk DA; Shaw LM; Morris JC; Trojanowski JQ; Fagan AM; Arnold SE; Hu WT
Alzheimers Res Ther; 2018 Sep; 10(1):98. PubMed ID: 30253800
[TBL] [Abstract][Full Text] [Related]
14. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
[TBL] [Abstract][Full Text] [Related]
15. Underlying Biological Processes in Mild Cognitive Impairment: Amyloidosis Versus Neurodegeneration.
Santana I; Baldeiras I; Santiago B; Duro D; Freitas S; Pereira MT; Almeida MR; Oliveira CR
J Alzheimers Dis; 2018; 64(s1):S647-S657. PubMed ID: 29562515
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
17. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
Hohman TJ; Bell SP; Jefferson AL;
JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
[TBL] [Abstract][Full Text] [Related]
18. Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study.
Miebach L; Wolfsgruber S; Polcher A; Peters O; Menne F; Luther K; Incesoy E; Priller J; Spruth E; Altenstein S; Buerger K; Catak C; Janowitz D; Perneczky R; Utecht J; Laske C; Buchmann M; Schneider A; Fliessbach K; Kalbhen P; Heneka MT; Brosseron F; Spottke A; Roy N; Teipel SJ; Kilimann I; Wiltfang J; Bartels C; Düzel E; Dobisch L; Metzger C; Meiberth D; Ramirez A; Jessen F; Wagner M
Alzheimers Res Ther; 2019 Jul; 11(1):66. PubMed ID: 31366409
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease.
Fagan AM; Xiong C; Jasielec MS; Bateman RJ; Goate AM; Benzinger TL; Ghetti B; Martins RN; Masters CL; Mayeux R; Ringman JM; Rossor MN; Salloway S; Schofield PR; Sperling RA; Marcus D; Cairns NJ; Buckles VD; Ladenson JH; Morris JC; Holtzman DM;
Sci Transl Med; 2014 Mar; 6(226):226ra30. PubMed ID: 24598588
[TBL] [Abstract][Full Text] [Related]
20. Discordant amyloid-β PET and CSF biomarkers and its clinical consequences.
de Wilde A; Reimand J; Teunissen CE; Zwan M; Windhorst AD; Boellaard R; van der Flier WM; Scheltens P; van Berckel BNM; Bouwman F; Ossenkoppele R
Alzheimers Res Ther; 2019 Sep; 11(1):78. PubMed ID: 31511058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
